Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,965
Closed -$518K 1418
2023
Q3
$518K Sell
8,965
-6,104
-41% -$385K 0.01% 931
2023
Q2
$938K Buy
+15,069
New +$1.01M 0.02% 723
2022
Q1
Sell
-4,805
Closed -$353K 1531
2021
Q4
$353K Sell
4,805
-219
-4% -$14.8K 0.01% 1157
2021
Q3
$345K Sell
5,024
-1,258
-20% -$95.6K 0.01% 1160
2021
Q2
$529K Buy
6,282
+3,302
+111% +$275K 0.01% 1008
2021
Q1
$242K Sell
2,980
-35
-1% -$2.99K ﹤0.01% 1266
2020
Q4
$262K Buy
3,015
+238
+9% +$20.6K 0.01% 1136
2020
Q3
$249K Buy
2,777
+27
+1% +$2.6K 0.01% 1067
2020
Q2
$286K Hold
2,750
0.01% 985
2020
Q1
$201K Buy
+2,750
New +$208K 0.01% 1031
2019
Q3
Sell
-3,224
Closed -$274K 1295
2019
Q2
$274K Sell
3,224
-75
-2% -$6.02K 0.01% 1040
2019
Q1
$284K Sell
3,299
-148
-4% -$12K 0.01% 1058
2018
Q4
$220K Buy
+3,447
New +$224K 0.01% 1067
2017
Q2
Sell
-3,265
Closed -$436K 1327
2017
Q1
$436K Buy
+3,265
New +$416K 0.01% 858
2015
Q3
Sell
-6,149
Closed -$641K 1409
2015
Q2
$641K Buy
+6,149
New +$636K 0.02% 776
2014
Q3
Sell
-4,068
Closed -$229K 1462
2014
Q2
$229K Sell
4,068
-20,797
-84% -$1.06M 0.01% 1191
2014
Q1
$1.33M Buy
24,865
+19,780
+389% +$1.23M 0.04% 501
2013
Q4
$257K Sell
5,085
-3,276
-39% -$143K 0.01% 1081
2013
Q3
$319K Buy
+8,361
New +$247K 0.01% 948

Other funds holding INCY

Oppenheimer & Co's INCY Position: Q4 2023 in Review

Oppenheimer & Co sold out of Incyte (INCY) in Q4 2023, closing a stake of 8,965 shares — an estimated $518K sold.

Oppenheimer & Co first reported a position in INCY in Q3 2013 and held it in 19 quarters. The position peaked at $1.33M in Q1 2014. 557 funds tracked by Wall St. Rank hold INCY as of Q4 2023.

  • Oppenheimer & Co reported no remaining Incyte position as of Q4 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 8,965 Incyte shares in Q4 2023, an estimated $518K.
  • Oppenheimer & Co first reported a position in Incyte in Q3 2013 and held it in 19 quarters.
  • Oppenheimer & Co's Incyte position peaked at $1.33M in Q1 2014.
  • 557 funds tracked by Wall St. Rank held Incyte as of Q4 2023.

Based on Oppenheimer & Co's 13F filing for Q4 2023, filed 13 Feb 2024.